Locations:
Search IconSearch
February 18, 2021/Cancer

Debunking Vaccine Myths for Your Patients

This op-ed offers a Cleveland Clinic expert's view

Covid-19 vaccine vials

Most physicians and medical professionals understand that the COVID-19 vaccines, especially the mRNA vaccines, are safe, effective and the best way out of this pandemic. The general public, however, is inundated with misinformation and may lack the scientific literacy necessary to dispel circulating myths. Many physicians and scientists are speaking out, offering their knowledge and perspective to a public that is both ready to end the pandemic and confused about vaccine safety and efficacy.

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

Suneel Kamath, MD, staff in the Department of Hematology and Medical Oncology at Cleveland Clinic Cancer Center, offers his expertise to the public in a recent article in U.S. News & World ReportDr. Kamath places the vaccines in the context of other drug studies for patients:

The concerns about theoretical long-term side effects of the COVID-19 vaccine are valid, but it’s important to contextualize them. The Pfizer vaccine has been studied in nearly 44,000 people, and the Moderna vaccine in 30,000 people, without any meaningful side effects or concerns for long-term issues. In comparison, most studies of the newest immunotherapy and personalized cancer drugs have less than 2,000 patients with minimal long-term safety data. Many people take supplements like cannabis oil or mushroom extracts without any evidence that these are safe long term. With vaccine studies this large and ongoing, there is no reason to scrutinize them any more than a new cancer drug or supplement.

Read the full article here, and consider sharing with patients who are hesitant to get vaccinated.

Advertisement

Related Articles

Dr. Khorana
April 25, 2025/Cancer/News & Insight
Molecular Insights into Early-Onset Biliary Tract Cancer (Podcast)

A call for awareness about the importance of genomic testing

Dr. Melenhorst
April 24, 2025/Cancer/News & Insight
Explore Developments in CAR T-Cell Therapy for CLL (Podcast)

Discussing research into improving CAR T-cell therapy efficacy

Dr. Cherian
April 23, 2025/Cancer/News & Insight
De-intensifying Radiation Therapy in Low-Risk Breast Cancer

Ultra-Hypofractionated Whole Breast Irradiation and Partial Breast Irradiation Reduce Many Toxicities

Pathology image
April 22, 2025/Cancer/News & Insight
Patient Case Study: Second Opinion Reveals Misdiagnosed Cancer

Patient receives liver transplant and a new lease on life

Clinician talking with patient
April 21, 2025/Cancer/News & Insight
Hematology Clinic Created to Support Spanish-Speaking Population

Lutheran Hospital team brings emerging treatments to community setting

Dr. Pennell and patient
April 10, 2025/Cancer/News & Insight
BiTE Therapy Emerges for Treating Small-Cell Lung Cancer

Hybrid treatment model helps improve cancer care access

Immune checkpoint inhibitor illustration
April 8, 2025/Cancer
Building on Initial Trial Data about New Immune Checkpoint Inhibitor for Treating Colorectal Cancer

Insights indicate that treatment may be beneficial beyond MSI-H tumors

Dr. Gerds with a patient
April 7, 2025/Cancer/News & Insight
Positive Results from Prospective, Randomized, Phase 3 Registrational Trial of Pelabresib + Ruxolitinib for JAK Inhibitor-Naive Myelofibrosis

Combination therapy doubles the number of meaningful spleen volume responses over monotherapy

Ad